GYRE THERAPEUTICS, INC. (GYRE)

(10% Negative) GYRE THERAPEUTICS, INC. (GYRE) Announces Delay in operations Trials for chronic hepatitis B (CHB)-induced liver fibrosis Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review

FASTLY, INC. (FSLY)

📋 Charles L. Compton III (Director) plans to sell 34K shares of Fastly, Inc. (at $19.50 each, total $663K) Filed: May 12, 2026 | ID: 000134